Quantum Biopharma (QNTM) Invested Capital (2019 - 2026)

Quantum Biopharma's Invested Capital history runs 8 years deep, the most recent figure standing at $595226.0 for Q1 2026.

• In Q1 2026, Invested Capital fell 89.62% year-over-year to $595226.0; the TTM figure through Mar 2026 stood at $595226.0 (down 89.62% YoY), while the FY2025 annual figure was $8.2 million, down 32.02% from the prior year.
• Invested Capital came in at $595226.0 for Q1 2026 at Quantum Biopharma, down from $8.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $30.5 million in Q4 2022 to a low of $595226.0 in Q1 2026.
• A 5-year average of $11.2 million and a median of $9.8 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital advanced 9.8% in 2024 and slumped 89.62% in 2026, its largest moves.
• Quantum Biopharma's Invested Capital stood at $30.5 million in 2022, then slumped by 51.42% to $14.8 million in 2023, then decreased by 18.44% to $12.1 million in 2024, then plunged by 32.02% to $8.2 million in 2025, then sank by 92.76% to $595226.0 in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $595226.0, $8.2 million, and $8.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison